TNBC is a BC that lacks the expression of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2), which precludes the targeted hormonal therapy options of other BC subtypes.13 This evidence concerns the gene WNK3 and breast cancer.